NNC-13571-71942
3 vaccinations
6 coded responses
29 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 605 / IL
- Registered
- 2021-01-11
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2021-01-11
Registered in v-safe
-
2021-01-11
Dose 2 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Oral herpes — Feeling: Fair · Muscle or body achesFree text: Cold soreMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Oral herpes — Feeling: Good · Muscle or body achesFree text: Cold soreMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-15
- 2021-01-16
-
2021-01-17
Survey response — days 1–6 daily, dose 2MedDRA: Cough — Feeling: Fair · Fatigue or tirednessFree text: Slight CoughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Survey response — day 7, dose 2MedDRA: Pharyngitis streptococcal, Streptococcal infection — Feeling: Fair · Fatigue or tiredness · Be unable to work, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Strep throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Report sent to call center — day 7, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-27
-
2021-02-01
Survey response — day 21, dose 2MedDRA: Hypertension — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: High blood pressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-10
- 2021-02-22
- 2021-04-12
- 2021-05-28
- 2021-07-13
- 2022-01-11
-
2022-01-15
Dose 3 — Pfizer-BioNTech
-
2022-01-16
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Muscle or body achesAdult check-in
-
2022-01-17
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-01-18
- 2022-01-19
-
2022-01-20
Health check-in — days 1–6 daily, dose 3Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2022-01-21
- 2022-01-24
- 2022-01-29
- 2022-02-05
- 2022-02-12
- 2022-02-21
- 2022-02-26
- 2022-04-18
- 2022-07-16
-
2023-01-19
Survey response — 12 months, dose 3MedDRA: Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-19
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-01-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-01-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-01-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-11 | Pfizer-BioNTech | |
| 3 | 2022-01-15 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 successful
1 wait over 3 months for a first call
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Cold sore
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Cold sore
Systemic reaction (other): Slight Cough
Release 2 — day 7, dose 2
Systemic reaction (other): Strep throat
Release 3 — day 21, dose 2
Symptoms: High blood pressure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hypertension | ✓ | ✓ | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Oral herpes | ✓ | ✓ | ✓ |
| SRO | Pharyngitis streptococcal | ✓ | · | ✓ |
| SRO | Streptococcal infection | ○ | ✓ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release